Lung Rx LLC, A Subsidiary Of United Therapeutics Corporation (UTHR), And Mondobiotech Announce Today a Global Strategic Partnership Agreement for the Development Of Aviptadil Platform
2/3/2010 2:04:00 PM
More...
|
23andMe, Inc. and Mondobiotech Partner to Advance Research of Rare Diseases
1/28/2009 10:00:31 AM
More...
|
The Day In Review: Biogen Idec, Inc. (Massachusetts) (BIIB) In-Licenses PAH Drug
9/14/2006 5:14:48 PM
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) And Mondobiotech Sign Collaboration And Licensing Agreement To Develop And Commercialize Aviptadil For Pulmonary Arterial Hypertension; mondoBIOTECH Will Receive Up To $30 Million
9/14/2006 8:26:42 AM
More...
|